ARCHIVES

FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion

This article is from The Cancer Letter archive.

Vol. 18 No. 01 | January 3, 1992

Download PDF Visit The Full Archive

Related Articles

Gardasil Approved To Prevent Vulvar And Vaginal Cancers

September 26, 2008

NCI Intramural Programs: Clinical Trials Support System Need Attention, report Advises DCS

December 19, 1997

Study Finds No Benefit for Frequent CA125 Testing in Recurrent Ovarian Cancer

June 5, 2009

In Brief: Subcommittee Okays $980 Million for NCI In 1983, House Passes Waxman Bill, With Centers Line Item

October 8, 1982

Obama Administration, WellPoint, Face Off Over Allegation Of Coverage Recissions

April 30, 2010

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

March 21, 2003